European Healthtech startup funding raised during Q2 2026.
In Q2 2026, 103 European Healthtech companies raised a combined €2.8B across 105 funding rounds, up 81.6% versus Q2 2025. UK led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Isomorphic Labs | Series B | May 2026 | €1.8B |
| CeQur | Series D+ | Jun 2026 | €86M |
| Ona Therapeutics | Series B | Jun 2026 | €74M |
| Uromems | Growth/Late |
| May 2026 |
| €52M |
| Storm Therapeutics | Series C | Apr 2026 | €48M |
| NVision Imaging | Series B | May 2026 | €47M |
| IMU Biosciences | Other | Jun 2026 | €45M |
| Leyden Labs | Other | Jun 2026 | €40M |
| Semble | Series C | Jun 2026 | €35M |
| Tissium | Other | Jun 2026 | €30M |
| Tissium | Debt | Jun 2026 | €30M |
| NUCLIDIUM | Series B | May 2026 | €29M |
| Prosper AI | Series A | Jun 2026 | €26M |
| Lightcast Discovery | Other | Apr 2026 | €23M |
| EnteroBiotix | Other | May 2026 | €22M |
